CD42d Antibodies

Santa Cruz Biotechnology offers a broad range of CD42d monoclonal antibodies for research focused on understanding this important protein. CD42d monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD42d, also known as glycoprotein V, is a critical component of the platelet receptor complex involved in the regulation of platelet activation and aggregation. Its function is essential for maintaining hemostasis and preventing excessive bleeding, making it a significant target for studies related to cardiovascular diseases and thrombotic disorders. Understanding the mechanisms of CD42d can provide insights into potential therapeutic strategies for managing these conditions. CD42d monoclonal antibodies enable precise detection and analysis of protein expression patterns across various experimental conditions. Researchers can utilize CD42d monoclonal antibodies to investigate protein-protein interactions and cellular localization patterns. Advanced research techniques incorporating CD42d monoclonal antibodies help unlock new discoveries in platelet biology. Santa Cruz Biotechnology monoclonal antibodies for CD42d support researchers worldwide in advancing our understanding of cardiovascular health and disease mechanisms.